头部和部状细胞癌中的B细胞:当前观点和新疗法
Xinyue Guo1, Licheng Xu1, Luan Nie1
1Department of Otorhinolaryngology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Cancer cell international
|January 20, 2024
概括
头支状细胞癌 (HNSCC) 的瘤微环境 (TME) 中的B细胞对于治疗疗效至关重要. 了解B细胞的作用和亚型可能会为HNSCC患者开启新的免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 头部和部状细胞癌 (HNSCC) 仍然是一个重大的健康挑战,尽管目前的治疗方法,但有一部分患者的预后不佳.
- 瘤微环境 (TME) 在癌症进展中起着至关重要的作用,通过复杂的细胞相互作用影响治疗反应.
- 虽然研究了HNSCC TME中的T细胞,但B细胞的功能在很大程度上仍未确定.
研究的目的:
- 为了研究B细胞在瘤微环境中的作用 (TME) 头部和部状细胞癌 (HNSCC).
- 探索不同的B细胞亚型和三级淋巴体结构 (TLSs) 对HNSCC免疫治疗疗效的影响.
- 根据TME中的B细胞功能来确定HNSCC潜在的未来免疫治疗方向.
主要方法:
- 对HNSCC瘤微环境 (TME) 中B细胞群和三级淋巴体结构 (TLSs) 的现有文献的综述.
- 对最近的研究分析,在HNSCC TME中确定了多种不同的B细胞亚型.
- B细胞存在和亚型与免疫检查点抑制剂 (ICI) 疗效的相关性.
主要成果:
- 最近的研究已经在HNSCC患者的瘤微环境 (TME) 中确定了各种B细胞亚型和三级淋巴体结构 (TLS).
- 这些B细胞群和TLS越来越多地被认为具有影响免疫检查点抑制剂 (ICI) 疗效的潜力.
结论:
- B细胞代表了HNSCC瘤微环境 (TME) 的关键,但尚未研究的组成部分.
- 对B细胞亚型及其在TME中的相互作用进行进一步的研究对于开发针对HNSCC的新型和有效免疫疗法至关重要.
- 向B细胞可能是一个有希望的途径,以改善头部和部状细胞癌的治疗结果.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921


